For: | Nishi Y, Isomoto H, Ueno H, Ohnita K, Wen CY, Takeshima F, Mishima R, Nakazato M, Kohno S. Plasma leptin and ghrelin concentrations in patients with Crohn’s disease. World J Gastroenterol 2005; 11(46): 7314-7317 [PMID: 16437634 DOI: 10.3748/wjg.v11.i46.7314] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i46/7314.htm |
Number | Citing Articles |
1 |
Amirmohammad Khalaji, Nastaran Babajani, Zahra Amirsardari, Behrad Saeedian, Soheil Peiman, Nathan A Berger, Amir Hossein Behnoush. Unveiling the Ghrelin and Obestatin Roles in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis Assessing Their Pathogenic Implications and Biomarker Utility. Inflammatory Bowel Diseases 2024; 30(4): 629 doi: 10.1093/ibd/izad202
|
2 |
Yuksel Ates, Bulent Degertekin, Ahmet Erdil, Halil Yaman, Kemal Dagalp. Serum Ghrelin Levels in Inflammatory Bowel Disease with Relation to Disease Activity and Nutritional Status. Digestive Diseases and Sciences 2008; 53(8): 2215 doi: 10.1007/s10620-007-0113-x
|
3 |
Roger Suau, Eva Pardina, Eugeni Domènech, Violeta Lorén, Josep Manyé. The Complex Relationship Between Microbiota, Immune Response and Creeping Fat in Crohn’s Disease. Journal of Crohn's and Colitis 2022; 16(3): 472 doi: 10.1093/ecco-jcc/jjab159
|
4 |
Konstantinos Karmiris, Ioannis E. Koutroubakis, Elias A. Kouroumalis. Leptin, adiponectin, resistin, and ghrelin – Implications for inflammatory bowel disease. Molecular Nutrition & Food Research 2008; 52(8): 855 doi: 10.1002/mnfr.200700050
|
5 |
Piotr Eder, Maciej Adler, Agnieszka Dobrowolska, Julian Kamhieh-Milz, Janusz Witowski. The Role of Adipose Tissue in the Pathogenesis and Therapeutic Outcomes of Inflammatory Bowel Disease. Cells 2019; 8(6): 628 doi: 10.3390/cells8060628
|
6 |
Larissa Gabriela Ferreira de Carvalho, William Gustavo Lima, Luiz Gonzaga Vaz Coelho, Valbert Nascimento Cardoso, Simone Odília Antunes Fernandes. Circulating Leptin Levels as a Potential Biomarker in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis. Inflammatory Bowel Diseases 2021; 27(2): 169 doi: 10.1093/ibd/izaa037
|
7 |
Mingrui Li, Benno Weigmann. A Novel Pathway of Flavonoids Protecting against Inflammatory Bowel Disease: Modulating Enteroendocrine System. Metabolites 2022; 12(1): 31 doi: 10.3390/metabo12010031
|
8 |
Shadi S. Yarandi, Gautam Hebbar, Cary G. Sauer, Conrad R. Cole, Thomas R. Ziegler. Diverse roles of leptin in the gastrointestinal tract: Modulation of motility, absorption, growth, and inflammation. Nutrition 2011; 27(3): 269 doi: 10.1016/j.nut.2010.07.004
|
9 |
Mark D. DeBoer. Use of Ghrelin as a Treatment for Inflammatory Bowel Disease: Mechanistic Considerations. International Journal of Peptides 2011; 2011: 1 doi: 10.1155/2011/189242
|
10 |
Fenming Zhang, Chengfu Xu, Longgui Ning, Fengling Hu, Guodong Shan, Hongtan Chen, Ming Yang, Wenguo Chen, Jiekai Yu, Guoqiang Xu, Kwang-Hyun Baek. Exploration of Serum Proteomic Profiling and Diagnostic Model That Differentiate Crohn's Disease and Intestinal Tuberculosis. PLOS ONE 2016; 11(12): e0167109 doi: 10.1371/journal.pone.0167109
|
11 |
Yanbo Yu, Wenjing Yang, Yanqing Li, Yingzi Cong. Enteroendocrine Cells: Sensing Gut Microbiota and Regulating Inflammatory Bowel Diseases. Inflammatory Bowel Diseases 2020; 26(1): 11 doi: 10.1093/ibd/izz217
|
12 |
Wen-Cai Qiu, Zhi-Gang Wang, Wei-Gang Wang, Jun Yan, Qi Zheng. Gastric motor effects of ghrelin and growth hormone releasing peptide 6 in diabetic mice with gastroparesis. World Journal of Gastroenterology 2008; 14(9): 1419-1424 doi: 10.3748/wjg.14.1419
|
13 |
Alessandra Gambero, Marta Maróstica, Mario José Abdalla Saad, José Pedrazzoli. Mesenteric adipose tissue alterations resulting from experimental reactivated colitis. Inflammatory Bowel Diseases 2007; 13(11): 1357 doi: 10.1002/ibd.20222
|
14 |
Eva Karaskova, Maria Velganova-Veghova, Milos Geryk, Hana Foltenova, Veronika Kucerova, David Karasek. Role of Adipose Tissue in Inflammatory Bowel Disease. International Journal of Molecular Sciences 2021; 22(8): 4226 doi: 10.3390/ijms22084226
|
15 |
V S Rodrigues, M Milanski, J J Fagundes, A S Torsoni, M L S Ayrizono, C E C Nunez, C B Dias, L R Meirelles, S Dalal, C S R Coy, L A Velloso, R F Leal. Serum levels and mesenteric fat tissue expression of adiponectin and leptin in patients with Crohn's disease. Clinical and Experimental Immunology 2012; 170(3): 358 doi: 10.1111/j.1365-2249.2012.04660.x
|
16 |
Flavia Merigo, Alessandro Brandolese, Sonia Facchin, Federico Boschi, Marzia Di Chio, Edoardo Savarino, Renata D’Incà, Giacomo Carlo Sturniolo, Andrea Sbarbati. Immunolocalization of leptin and leptin receptor in colorectal mucosa of ulcerative colitis, Crohn’s disease and control subjects with no inflammatory bowel disease. Cell and Tissue Research 2021; 383(3): 1103 doi: 10.1007/s00441-020-03297-4
|
17 |
Jan Bilski, Agnieszka Mazur-Bialy, Dagmara Wojcik, Marcin Surmiak, Marcin Magierowski, Zbigniew Sliwowski, Robert Pajdo, Slawomir Kwiecien, Aleksandra Danielak, Agata Ptak-Belowska, Thomas Brzozowski. Role of Obesity, Mesenteric Adipose Tissue, and Adipokines in Inflammatory Bowel Diseases. Biomolecules 2019; 9(12): 780 doi: 10.3390/biom9120780
|
18 |
Agata Michalak, Beata Kasztelan-Szczerbińska, Halina Cichoż-Lach. Impact of Obesity on the Course of Management of Inflammatory Bowel Disease—A Review. Nutrients 2022; 14(19): 3983 doi: 10.3390/nu14193983
|
19 |
H O Al-Hassi, D Bernardo, A U Murugananthan, E R Mann, N R English, A Jones, M A Kamm, N Arebi, A L Hart, A I F Blakemore, A J Stagg, S C Knight. A mechanistic role for leptin in human dendritic cell migration: differences between ileum and colon in health and Crohn's disease. Mucosal Immunology 2013; 6(4): 751 doi: 10.1038/mi.2012.113
|
20 |
Giorgos Chouliaras, Ioanna Panayotou, Daphne Margoni, Emilia Mantzou, Panagiota Pervanidou, Yannis Manios, George P. Chrousos, Eleftheria Roma. Circulating leptin and adiponectin and their relation to glucose metabolism in children with Crohn’s disease and ulcerative colitis. Pediatric Research 2013; 74(4): 420 doi: 10.1038/pr.2013.114
|
21 |
Sotirios Terzoudis, Christos Zavos, Ioannis E. Koutroubakis. The Bone and Fat Connection in Inflammatory Bowel Diseases. Inflammatory Bowel Diseases 2014; 20(11): 2207 doi: 10.1097/MIB.0000000000000111
|
22 |
Barbara Ruszkowska, Alina Sokup, Arleta Kulwas, Maciej W. Socha, Krzysztof Góralczyk, Barbara Góralczyk, Danuta Rość. Assessment of ghrelin and leptin receptor levels in postmenopausal women who received oral or transdermal menopausal hormonal therapy. Journal of Zhejiang University SCIENCE B 2012; 13(1): 35 doi: 10.1631/jzus.B1100276
|
23 |
Luzia Valentini, Eva Katrin Wirth, Ulrich Schweizer, Susanne Hengstermann, Lennart Schaper, Thomas Koernicke, Ekkehart Dietz, Kristina Norman, Carsten Buning, Brigitte M. Winklhofer-Roob, Herbert Lochs, Johann Ockenga. Circulating adipokines and the protective effects of hyperinsulinemia in inflammatory bowel disease. Nutrition 2009; 25(2): 172 doi: 10.1016/j.nut.2008.07.020
|
24 |
Tomohito Morisaki, Fuminao Takeshima, Hiroko Fukuda, Kayoko Matsushima, Yuko Akazawa, Naoyuki Yamaguchi, Ken Ohnita, Hajime Isomoto, Hiroaki Takeshita, Terumitsu Sawai, Fumihiko Fujita, Kazuhiko Nakao. High Serum Vaspin Concentrations in Patients with Ulcerative Colitis. Digestive Diseases and Sciences 2014; 59(2): 315 doi: 10.1007/s10620-013-2905-5
|
25 |
Su Hwan Kim, Seung Hyeon Jang, Ji Won Kim, Byeong Gwan Kim, Kook Lae Lee, You Sun Kim, Dong Soo Han, Joo Sung Kim. Serum Adipocytokine Levels as Surrogate Markers for Disease Activity of Crohn’s Disease. The American Journal of the Medical Sciences 2017; 353(5): 439 doi: 10.1016/j.amjms.2017.02.006
|
26 |
J.J. Worthington, F. Reimann, F.M. Gribble. Enteroendocrine cells-sensory sentinels of the intestinal environment and orchestrators of mucosal immunity. Mucosal Immunology 2018; 11(1): 3 doi: 10.1038/mi.2017.73
|
27 |
Lorena Ortega Moreno, Ancor Sanz-Garcia, Marina J. Fernández de la Fuente, Ricardo Arroyo Solera, Samuel Fernández-Tomé, Alicia C. Marin, Irene Mora-Gutierrez, Paloma Fernández, Montserrat Baldan-Martin, María Chaparro, Javier P. Gisbert, David Bernardo. Serum adipokines as non-invasive biomarkers in Crohn’s disease. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-74999-6
|